ASSET | DATE | % RETURN |
---|---|---|
error (ZVZZT) | 9/1/2023 - 9/14/2023 | 5,816.58% |
Oncology Institute (TOIIW) | 9/1/2023 - 9/14/2023 | 203.14% |
Nexalin Technology (NXLIW) | 9/1/2023 - 9/14/2023 | 159.14% |
Theratechnologies (THTX) | 9/1/2023 - 9/14/2023 | 156.52% |
Aclarion (ACONW) | 9/1/2023 - 9/14/2023 | 150% |
Avalo Therapeutics (AVTX) | 9/1/2023 - 9/14/2023 | 118.5% |
Brand Engagement Network (BNAIW) | 9/1/2023 - 9/14/2023 | 104.08% |
Shengfeng Development Limited Class A Ordinary Shares (SFWL) | 9/1/2023 - 9/14/2023 | 99.38% |
Canopy Growth (CGC) | 9/1/2023 - 9/14/2023 | 98.44% |
Prenetics (PRENW) | 9/1/2023 - 9/14/2023 | 94.93% |
EUDA Health (EUDAW) | 9/1/2023 - 9/14/2023 | 93.09% |
LMF Acquisition Opportunities (ICUCW) | 9/1/2023 - 9/14/2023 | 85.19% |
Reviva Pharmaceuticals (RVPHW) | 9/1/2023 - 9/14/2023 | 81.1% |
Myomo (MYO) | 9/1/2023 - 9/14/2023 | 74.2% |
ADS-TEC ENERGY PLC Warrant (ADSEW) | 9/1/2023 - 9/14/2023 | 71.57% |
Wheels Up Experience (UP) | 9/1/2023 - 9/14/2023 | 68.95% |
Crinetics Pharmaceuticals (CRNX) | 9/1/2023 - 9/14/2023 | 67.31% |
Aurora Cannabis (ACB) | 9/1/2023 - 9/14/2023 | 62.29% |
Entero Therapeutics (ENTO) | 9/1/2023 - 9/14/2023 | 59.75% |
GeoVax Labs (GOVXW) | 9/1/2023 - 9/14/2023 | 59.34% |
NextNav Inc Warrant (NNAVW) | 9/1/2023 - 9/14/2023 | 58.54% |
Foxx Development (FOXXW) | 9/1/2023 - 9/14/2023 | 52.44% |
Rocket Pharmaceuticals (RCKT) | 9/1/2023 - 9/14/2023 | 52.02% |
Moolec Science SA Warrant (MLECW) | 9/1/2023 - 9/14/2023 | 50.63% |
Reviva Pharmaceuticals (RVPH) | 9/1/2023 - 9/14/2023 | 49.37% |